A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug

NCT01888445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Anemia Associated With Chronic Renal Failure (CRF)

Interventions

DRUG: roxadustat
DRUG: darbepoetin alfa

Sponsor

Astellas Pharma Inc